主要免疫抑制剂在紫外线炎中的失效
Ankush Kawali1, Sara Rizvi1, Sai Bhakti Mishra1
1Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, Karnataka, India.
Indian journal of ophthalmology
|May 28, 2025
概括
管理耐火性非传染性脑膜炎 (NIU) 通常需要组合免疫调节疗法 (IMT). 甲托雷克萨特 (MTx) 加上mycophenolate mofetil (MMF) 是常见的,像托法西提尼布 (Tofa) 这样的生物药物显示出希望,特别是在Vogt-Koyanagi-Harada (VKH) 疾病中.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 非传染性脑膜炎 (NIU) 带来了重大管理挑战,特别是在耐火病例中.
- 初级免疫调节疗法 (IMT) 的失败需要探索替代和组合治疗策略.
- 了解需要IMT修订的患者的治疗模式和有效性,对于优化护理至关重要.
研究的目的:
- 评估各种免疫调节疗法 (IMT) 对非传染性脑膜炎 (NIU) 治疗方案的有效性.
- 为了确定耐火性NIU病例的最佳治疗策略,这些病例已经失败了初级IMT.
- 分析因不受控制的炎症或复发而需要IMT修订的患者的治疗模式和结果.
主要方法:
- 追溯研究分析了2023年12月至2024年11月的数据.
- 纳入标准:患有NIU,结核炎或表皮结核炎的患者,初级IMT失败.
- 分析初级IMT疗法和随后的修订,包括组合疗法和生物药物.
主要成果:
- 该队列包括54名患者;帕努韦炎是最常见的诊断 (44.4%).
- 甲托雷克萨特 (MTx) 是主要的主要IMT (83.3%).
- 第一次IMT修订经常涉及组合治疗 (MTx + mycophenolate mofetil [MMF] 在24.1%). 随后的修订显示了生物药物的使用增加 (阿达利穆马布[ADA],托法西提尼布[Tofa]). 沃格特-科亚纳吉-哈拉达 (VKH) 疾病在患有初级IMT失败的人群中很常见,后来的修订中增加了Tofa的使用.
结论:
- 耐火性NIU管理具有挑战性,通常需要组合IMT.
- 经常使用MMF和MTx的联合治疗.
- 像Tofa这样的生物药物是一个有价值的选择,特别是在VKH疾病中,需要在前性研究中进一步调查.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
212
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
212
Open Angle Glaucoma: Treatment
597
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
597
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244
Glaucoma: Overview
792
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
792
Angle Closure Glaucoma: Treatment
718
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
718


